Persistently high quality of life conferred by coexisting congenital deficiency of terminal complement C9 in a paroxysmal nocturnal hemoglobinuria patient-Reference-Cited by-同舟云学术

Persistently high quality of life conferred by coexisting congenital deficiency of terminal complement C9 in a paroxysmal nocturnal hemoglobinuria patient

Published:2012-04-19 Issue:16 Volume:119 Page:3866-3868
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Hanaoka Nobuyoshi¹,Murakami Yoshiko²,Nagata Masahide³,Nagakura Shoichi⁴,Yonemura Yuji⁵,Sonoki Takashi¹,Kinoshita Taroh²,Nakakuma Hideki¹

Affiliation:

1. Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan

2. Research Institute for Microbial Diseases, and WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan

3. Nagata ENT Clinic, Kumamoto, Japan

4. Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan

5. Department of Blood Transfusion Medicine and Cell Therapy, Kumamoto University, Kumamoto, Japan

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/119/16/3866/1476464/zh801612003866.pdf

Reference10 articles.

1. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.;Hillmen;N Engl J Med,2004

2. Eculizumab for paroxysmal nocturnal haemoglobinuria.;Parker;Lancet,2009

3. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.;Kelly;Blood,2011

4. Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization.;Hill;Haematologica,2010

5. Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab.;Risitano;Blood,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells;American Journal of Hematology;2024-01-24

2. The long‐acting anti‐C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab;British Journal of Haematology;2023-01-19

3. Occupancy of whole blood cells by a singlePIGA-mutant clone withHMGA2amplification in a paroxysmal nocturnal haemoglobinuria patient having blood cells with NKG2D ligands;British Journal of Haematology;2012-10-18